Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

31,500

Employees31,500

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

31,500

Employees31,500

AMGN Key Statistics

Market cap

195.38B

Market cap195.38B

Price-Earnings ratio

25.07

Price-Earnings ratio25.07

Dividend yield

2.72%

Dividend yield2.72%

Average volume

3.51M

Average volume3.51M

High today

$362.78

High today$362.78

Low today

$356.87

Low today$356.87

Open price

$362.10

Open price$362.10

Volume

2.24M

Volume2.24M

52 Week high

$391.29

52 Week high$391.29

52 Week low

$269.77

52 Week low$269.77

Stock Snapshot

With a market cap of 195.38B, Amgen(AMGN) trades at $362.12. The stock has a price-to-earnings ratio of 25.07 and currently yields dividends of 2.72%.

On 2026-06-30, Amgen(AMGN) stock moved within a range of $356.87 to $362.78. With shares now at $362.12, the stock is trading +1.5% above its intraday low and -0.2% below the session's peak.

Trading volume for Amgen(AMGN) stock has reached 2.24M, versus its average volume of 3.51M.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $269.77.

AMGN News

CNBC 6h

Final Trades: Apple, Palo Alto Networks, Micron and Amgen - CNBC

...

TipRanks 6h

CodeBreaK 100: Amgen’s KRAS Trial Update and What It Means for AMGN Investors

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more c...

Nasdaq 12h

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

Key Points Cisco Systems is on a roll with its AI-powered platform. Coca-Cola saw volume growth in each of its marketing segments in the first quarter. Amgen...

Analyst ratings

50%

of 34 ratings

Buy

38.2%

Hold

50%

Sell

11.8%

More AMGN News

TipRanks 1d

Trial used to approve Amgen’s Tavneos retracted from NEJM

A clinical trial, originally published in 2021, which was used to approve Amgen’s (AMGN) Tavneos was retracted Monday from the New England Journal of Medicine a...

The Wall Street Journal 4d

European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked

The European Medicines Agency has called for Amgen’s Tavneos—a medication for two rare inflammatory conditions of the blood vessels—to have its marketing author...

Simply Wall St 6d

Willful Patent Verdict and Possible Treble Damages Could Be A Game Changer For Amgen

In June 2026, a Delaware jury found that Amgen and its subsidiary Teneobio willfully infringed Harbour BioMed’s Grosveld patent, awarding Harbour US$20,203,704...

Nasdaq 7d

Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Amgen provides a stable, diversified revenue base of nearly $36.7 billion with significant net income. Iovance Biotherapeutics offers high growth p...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.